Correlation Between Beam Therapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on Beam Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Lyra Therapeutics.
Diversification Opportunities for Beam Therapeutics and Lyra Therapeutics
0.24 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Beam and Lyra is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Beam Therapeutics and Lyra Therapeutics
Given the investment horizon of 90 days Beam Therapeutics is expected to generate 1.91 times more return on investment than Lyra Therapeutics. However, Beam Therapeutics is 1.91 times more volatile than Lyra Therapeutics. It trades about 0.37 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about 0.22 per unit of risk. If you would invest 2,344 in Beam Therapeutics on November 18, 2024 and sell it today you would earn a total of 896.00 from holding Beam Therapeutics or generate 38.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Beam Therapeutics vs. Lyra Therapeutics
Performance |
| Timeline |
| Beam Therapeutics |
| Lyra Therapeutics |
Beam Therapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Beam Therapeutics and Lyra Therapeutics
The main advantage of trading using opposite Beam Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |